Northwest Wealth Management LLC Purchases Shares of 1,167 CME Group Inc. (NASDAQ:CME)

Northwest Wealth Management LLC purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,167 shares of the financial services provider's stock, valued at approximately $310,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. New Age Alpha Advisors LLC increased its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares in the last quarter. Golden State Wealth Management LLC increased its position in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares in the last quarter. Alpine Bank Wealth Management bought a new stake in shares of CME Group during the first quarter worth about $32,000. Knuff & Co LLC bought a new stake in shares of CME Group during the fourth quarter worth about $33,000. Finally, Banque Transatlantique SA bought a new stake in shares of CME Group during the fourth quarter worth about $35,000. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CME. Barclays upped their price objective on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price for the company in a research report on Monday, March 10th. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Morgan Stanley increased their target price on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Finally, Royal Bank Of Canada reissued a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $258.20.

Insider Activity at CME Group

In other CME Group news, Director Larry G. Gerdes sold 2,000 shares of the firm's stock in a transaction on Thursday, April 24th. The shares were sold at an average price of $264.10, for a total value of $528,200.00. Following the sale, the director now owns 38,651 shares of the company's stock, valued at $10,207,729.10. This trade represents a 4.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel G. Kaye sold 500 shares of the firm's stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director now directly owns 3,668 shares in the company, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,400 shares of company stock valued at $3,680,610. Insiders own 0.30% of the company's stock.

CME Group Stock Performance

CME Group stock opened at $274.76 on Monday. The firm's fifty day moving average price is $275.21 and its 200-day moving average price is $256.83. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $99.01 billion, a P/E ratio of 27.64, a price-to-earnings-growth ratio of 3.73 and a beta of 0.45. CME Group Inc. has a fifty-two week low of $193.17 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $2.50 EPS. On average, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.